Literature DB >> 3821226

Predictors of physician prescribing change in an educational experiment to improve medication use.

S B Soumerai, J Avorn.   

Abstract

In analyzing a university-based program to educate physicians about proper medication use, we sought to measure whether physician background characteristics and the quality or number of educational exposures influenced the rate of relinquishment of inappropriate prescribing. A sample of 435 doctors was randomized to control and experimental groups; interventions consisted of printed educational materials and face-to-face visits by clinical pharmacists. The program sought to reduce inappropriate use of three drug categories: propoxyphene, peripheral/cerebral vasodilators, and cephalexin. Outcome data included the total volume (tablets/capsules) of these drugs prescribed through Medicaid by each study physician 9 months before and after the program. We estimated average changes in prescribing levels by experimental and control physicians within each physician subgroup (e.g., board-certified versus uncertified), adjusting for prescribing level in the same 9 months of the previous year. The results indicated that the rate of prescribing change was independent of most physician background characteristics studied, including age, board certification, specialty, rural versus urban practice, intensity of previous target drug use, and size of Medicaid practice. Experimental effects were highly significant (-9% to -20%, P less than 0.025) in 11 of 14 physician subgroups. The presence of a follow-up reinforcement visit was a strong independent predictor of prescribing change (P less than 0.05). An increase from one visit to two visits was associated with an approximate doubling of the size of the program effect. However, total exposure time was not related to changes in prescribing behavior. These findings document that face to face education can be effective in improving the prescribing practices of a wide variety of physicians, and that brevity, repetition, and reinforcement of recommended practices are important components in the design of such programs.

Entities:  

Mesh:

Year:  1987        PMID: 3821226     DOI: 10.1097/00005650-198703000-00005

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  18 in total

1.  A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs.

Authors:  Ann Jacoby; Monica Smith; Martin Eccles
Journal:  Br J Gen Pract       Date:  2003-02       Impact factor: 5.386

Review 2.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

3.  Changing preventive practice: a controlled trial on the effects of outreach visits to organise prevention of cardiovascular disease.

Authors:  M E Hulscher; B B van Drenth; J C van der Wouden; H G Mokkink; C van Weel; R P Grol
Journal:  Qual Health Care       Date:  1997-03

Review 4.  Implementing guidelines in general practice care.

Authors:  R Grol
Journal:  Qual Health Care       Date:  1992-09

5.  Drug use in Swedish nursing homes.

Authors:  C B Claesson; I K Schmidt
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

6.  The Doctor's, the Druggist's, and the Detail Rep's Dance: Who leads, who follows?

Authors:  J P Rovers
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

7.  Prescribing by canadian general practitioners: review of the english language literature.

Authors:  J Lexchin
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

Review 8.  Printed educational materials: effects on professional practice and healthcare outcomes.

Authors:  Anik Giguère; France Légaré; Jeremy Grimshaw; Stéphane Turcotte; Michelle Fiander; Agnes Grudniewicz; Sun Makosso-Kallyth; Fredric M Wolf; Anna P Farmer; Marie-Pierre Gagnon
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

9.  Quality control and drug utilization review.

Authors:  A I Wertheimer
Journal:  Pharm Weekbl Sci       Date:  1988-08-19

10.  Space-Time Cluster Analysis to Detect Innovative Clinical Practices: A Case Study of Aripiprazole in the Department of Veterans Affairs.

Authors:  Robert B Penfold; James F Burgess; Austin F Lee; Mingfei Li; Christopher J Miller; Marjorie Nealon Seibert; Todd P Semla; David C Mohr; Lewis E Kazis; Mark S Bauer
Journal:  Health Serv Res       Date:  2016-12-22       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.